Beijing Hongrun Tianyuan Gene Biotechnology Co., Ltd.

Beijing Cellonis Biotechnologies Co., Ltd. was founded in 2004, with a professional technical team jointly established by the University of Michigan and Peking University, and is a high-tech enterprise in Beijing. On July 23, 2015, Beijing Cellonis Biotechnologies Co., Ltd. was officially listed on the New Third Board (securities abbreviation: "Hongtian Biotech", stock code 832979).
The company owns a research and development laboratory with a total area of 2,000 square meters, a biological resource bank with a storage capacity of 320,000 samples, and has passed the international ISO9001 quality system certification.
In 2014, Hongtian Biotech became a member of the International Society for Cell Therapy (ISCT), and its cell application quality reached international standards.
Hongtian Biotech is committed to building a complete, high-quality whole industry chain ecological system, establishing branch banks in key cities such as Beijing, Shanghai, and Shenzhen, to create the largest comprehensive biological sample bank and technical service platform in Asia.

Company scale: 101-499 employees
Company nature: Listed company
Company industry: Bioengineering